The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
6751576 7409277 I 6751576-0 20100513 20100514 20100526 EXP TCI2010A01836 TAKEDA PHARMACEUTICALS NORTH AMERICA. 60 YR F N 20100525 MD JAPAN

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
6751576 1013793533 PS ACTOS 1 ORAL 15 MG (15 MG, 1 IN 1 D), PER ORAL U D 21073
6751576 1013806577 C INTERFERON 1

Indications of drugs used

Event ID DRUG SEQ INDI PT
6751576 1013793533 DIABETES MELLITUS

Outcome of event

Event ID OUTC COD
6751576 HO

Reactions reported

Event ID PT
6751576 DECREASED APPETITE
6751576 DEHYDRATION

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
6751576 FGN
6751576 HP
6751576 OTH

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
6751576 1013793533 20100510 20100513 3 DAY